MF
EIDX

Magnetar Financial’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Magnetar Financial’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-599,330
Closed -$78.9M – 1346
2020
Q4 		$78.9M Buy
+599,330
New +$53M 1.11% 16

Magnetar Financial's EIDX Position: Q1 2021 in Review

Magnetar Financial sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 599,330 shares — an estimated $78.9M sold.

Magnetar Financial first reported a position in EIDX in Q4 2020 and held it in 1 quarter. The position peaked at $78.9M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

  • Magnetar Financial reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Magnetar Financial sold 599,330 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $78.9M.
  • Magnetar Financial first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Magnetar Financial's Eidos Therapeutics, Inc. Common Stock position peaked at $78.9M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Magnetar Financial's 13F filing for Q1 2021, filed 14 May 2021.